The role of the KSHI Advisory Committee is to advise, assist, and support the KSHI to ensure that it is well-established and well-resourced with the needed expertise and materials to create an innovation platform that is able to attract highly qualified academics, scientists, and clinicians as well as to establish world-class training programs and a network of stakeholders (including universities, hospitals, industry, and start-ups) to drive precision medicine and to address the Kingdom’s current gaps in clinical care and research and development (R&D).

Advisory Committee board members

Professor Pierre Magistretti

Chairman | Director, KAUST Smart-Health Initiative

Professor Imed Gallouzi

Co-chairman | Associate Director, KAUST Smart-Health Initiative

Professor Vassilios Papadopoulos

Member | Dean, School of Pharmacy, University of Southern California

Professor Francis Waldvogel

Member | Former Chair of the Novartis Fund

Professor Matthias Hentze

Member | Director, European Molecular Biology Laboratory (EMBL)

Professor John Aitchison

Member | Professor, Department of Pediatrics, University of Washington, Seattle

Professor Ali Alzahrani

Member | Professor of Medicine and Endocrinology, Alfaisal University

Professor Nancy Yuk-Yu IP

Member | Vice-President for Research and Development, The Morningside Professor of Life Science